GlassScriptPhysician profile
Irina Belder
NPI 1215115407
$4,916.30
in general payments reported to CMS, 2019-2025
28 companies · $882 in 2025
The $882 reported for 2025 was more than what 84% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $754 · 2020: $715 · 2021: $618 · 2022: $689 · 2023: $749 · 2024: $510 · 2025: $882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,140.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,167.23 | 2020-2025 | Puraply, Apligraf, Puraply Antimicrobial |
| Abbott Laboratories | $505.80 | 2019-2025 | Esprit |
| Smith+Nephew, INC. | $378.22 | 2021-2025 | Regranex, Collagenase Santyl, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Angiodynamics, INC. | $276.64 | 2021-2024 | Auryon Laser System 100-120 Vac |
| Bioventus LLC | $264.59 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $244.21 | 2019-2020 | |
| Medtronic Vascular, INC. | $182.18 | 2019-2020 | |
| Advanced Oxygen Therapy INC. | $145.43 | 2022-2024 | Topical Oxygen Chamber For Extremities |
| Paratek Pharmaceuticals, INC. | $140.73 | 2024 | Nuzyra |
| Allergan, INC. | $125.00 | 2019 | |
| Osiris Therapeutics INC. | $124.08 | 2019 | |
| Stability Biologics, LLC | $123.70 | 2021 | |
| Amgen INC. | $122.21 | 2025 | Krystexxa |
| Treace Medical Concepts, INC. | $121.90 | 2022 | |
| Kci USA, INC. | $121.43 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $121.03 | 2025 | Jublia |
| Celularity INC. | $111.93 | 2020 | |
| Triad Life Sciences INC. | $109.13 | 2022 | |
| Cagent Vascular INC | $88.50 | 2023 | Serrantor |
| Baxter Healthcare | $87.74 | 2019 | |
| Sebela Pharmaceuticals INC. | $76.69 | 2020-2022 | |
| Tactile Systems Technology INC | $71.72 | 2025 | Flexitouch Plus, Nimbl |
| Abbvie INC. | $69.40 | 2021 | |
| Kerecis Limited | $46.90 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Next Science LLC | $29.47 | 2024 | Xperience, Surgx, Blastx |
| Convatec INC. | $25.63 | 2023 | |
| Biocomposites INC | $22.86 | 2025 | Stimulan |
| Hartmann USA, INC. | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Belder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.